Zacks Investment Research on MSN

FDA approves Novo Nordisk's higher-dose Wegovy for obesity patients

Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess ...

Rhythm's therapy becomes first FDA-approved treatment for brain damage-related obesity

By Sneha S K and Sahil Pandey March 20 (Reuters) - The U.S. Food and Drug Administration expanded the use of Rhythm ...